<b>Conclusions</b>: Radiotherapy significantly increases contralateral breast cancer risk, particularly in ATM and CHEK2 carriers, emphasizing the importance of personalized genetic risk stratification in treatment decisions. This evidence concerns the gene CHEK2 and breast carcinoma.